{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/cough-acute-with-chest-signs-in-children/prescribing-information/doxycycline/","result":{"pageContext":{"chapter":{"id":"64d06ec1-7d56-574c-a9cc-ee35cfd204e4","slug":"doxycycline","fullItemName":"Doxycycline","depth":2,"htmlHeader":"<!-- begin field c5f7a5c3-7868-4b21-bc7b-a70100f5915c --><h2>Doxycycline</h2><!-- end field c5f7a5c3-7868-4b21-bc7b-a70100f5915c -->","summary":"","htmlStringContent":"<!-- begin item e93ae89e-131c-4734-b120-a70100f58d50 --><!-- end item e93ae89e-131c-4734-b120-a70100f58d50 -->","topic":{"id":"ecc57759-d8a2-50b5-addc-68127dd57e13","topicId":"6f239a86-8a9f-4fc1-85b2-df045fbf9477","topicName":"Cough - acute with chest signs in children","slug":"cough-acute-with-chest-signs-in-children","lastRevised":"Last revised in January 2021","chapters":[{"id":"82620eeb-35c8-583d-957c-c8c9d68f0bc4","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"85e154c6-7444-55c1-8105-4238c565d6d6","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"34d842b6-5846-5142-96f5-6451b7b9503f","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"94ebcc3a-8e44-5c7a-84a1-44c122e86fc5","slug":"changes","fullItemName":"Changes"},{"id":"19991281-8b30-5f16-8552-ba71a6c2257f","slug":"update","fullItemName":"Update"}]},{"id":"31245ad9-f63e-5053-8f0f-9e310f133212","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"b1846e94-64be-5a1d-b26e-9bc518192b43","slug":"goals","fullItemName":"Goals"},{"id":"52d51fe3-1e3c-5479-82e5-628353de2bda","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"59199121-d653-59c9-a7ff-03835d711500","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"73cf3120-d25a-5284-8593-e93c81d39c8d","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"4f7d288f-bf0c-5dd9-aad8-54ef82e7e039","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"60fdd9e2-e6fd-5e5b-98d4-33afb2271bf6","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"40cbe9e5-667a-56f8-9039-e094f48e40da","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"b9756443-edc1-5707-af00-970491b93f52","slug":"definition","fullItemName":"Definition"},{"id":"ef20d952-44e6-5372-8021-cb07f3444dc1","slug":"prevalence","fullItemName":"Prevalence"},{"id":"39f5f767-cf1c-554f-ac8c-1c89c7b73a53","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"eee4bb33-4743-5ff3-b4e0-221f6f6670c7","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"476813be-e2a1-5849-b379-e674dda72f03","slug":"diagnosis-of-cause","fullItemName":"Diagnosis of cause"},{"id":"b9d5f16f-3395-562d-a46b-b1f06bd6bed5","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"899fa269-48ce-5ff0-82b9-83b8bbd23fd5","fullItemName":"Management","slug":"management","subChapters":[{"id":"a34c98a9-afaf-51ce-9449-23569af98723","slug":"viral-induced-wheeze-possible-asthma","fullItemName":"Scenario: Viral-induced wheeze/possible asthma"},{"id":"87edfa6f-d156-5750-9778-a82799c16245","slug":"bronchiolitis","fullItemName":"Scenario: Bronchiolitis"},{"id":"aa61e13e-692a-56aa-a17b-a9429aa076d0","slug":"community-acquired-pneumonia","fullItemName":"Scenario: Community-acquired pneumonia"}]},{"id":"e3645b31-0302-5b3c-ad3d-fad31e7f02f9","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"f1a05b5b-c5fe-5138-a544-4d447c78a07e","slug":"amoxicillin-co-amoxiclav","fullItemName":"Amoxicillin and co-amoxiclav"},{"id":"82dc91ea-2a15-5ea8-979f-6ff8f0d34a7a","slug":"cefaclor","fullItemName":"Cefaclor"},{"id":"64d06ec1-7d56-574c-a9cc-ee35cfd204e4","slug":"doxycycline","fullItemName":"Doxycycline"},{"id":"20c13e81-9ef3-5df6-9f51-eb0dfacaaeab","slug":"ibuprofen-paracetamol","fullItemName":"Ibuprofen and paracetamol"},{"id":"87a5f8d7-3f8e-5b8e-81b4-364a14a73467","slug":"macrolides","fullItemName":"Macrolides"},{"id":"0697a2ca-e9c2-512d-ab11-d573f39abddf","slug":"prednisolone","fullItemName":"Prednisolone"},{"id":"f40afbec-15db-5ba5-8bf8-b4ddeee5aeec","slug":"short-acting-beta-2-agonists","fullItemName":"Short-acting beta-2 agonists"}]},{"id":"91f18501-a585-5063-808d-45ce72bc128b","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"87a7a774-5455-587b-b324-53fd94fb5173","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"0ddbcc1e-d9b8-5a7f-becd-f71b188dbbd0","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"d35bce52-adec-5cb7-9ea1-acf95169edd6","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"a68992e4-ba15-5c95-9370-e987b9a61f0e","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"610e5926-a430-5217-a4dc-6de7f4a3d7c8","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"d9335bd0-caf6-5162-a6c3-4efb35bf6011","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"b3e96fe7-7269-59f4-8328-c9710f4dbc76","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"e3645b31-0302-5b3c-ad3d-fad31e7f02f9","slug":"prescribing-information","fullItemName":"Prescribing information"},"subChapters":[{"id":"cd3fde87-fe47-5876-807f-753f1284b07b","slug":"contraindications-cautions","fullItemName":"Contraindications and cautions","depth":3,"htmlHeader":"<!-- begin field 47e6eb02-254b-4957-a8a0-a70100fb1c14 --><h3>Contraindications and cautions</h3><!-- end field 47e6eb02-254b-4957-a8a0-a70100fb1c14 -->","summary":"","htmlStringContent":"<!-- begin item 4f4062d1-3f1c-48c7-8924-a70100fb16db --><!-- begin field 7aa95f57-2d1c-4e09-a398-a70100fb1c14 --><p><strong>Do not prescribe doxycycline to:</strong></p><ul><li>Children under 12 years of age.</li><li>Girls who are pregnant or breastfeeding.</li><li>People with:<ul><li>Liver disease.</li><li>Systemic lupus erythematosus.</li><li>Myasthenia gravis.</li><li>Porphyria.</li></ul></li></ul><p> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/cough-acute-with-chest-signs-in-children/references/\">ABPI, 2016a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/cough-acute-with-chest-signs-in-children/references/\">BNF 72, 2016</a>]</p><!-- end field 7aa95f57-2d1c-4e09-a398-a70100fb1c14 --><!-- end item 4f4062d1-3f1c-48c7-8924-a70100fb16db -->","subChapters":[]},{"id":"7c420854-2ccd-5798-973e-dff9cb8ac260","slug":"adverse-effects","fullItemName":"Adverse effects","depth":3,"htmlHeader":"<!-- begin field 8b4ececa-54b6-4cfa-a272-a70100fb3610 --><h3>Adverse effects</h3><!-- end field 8b4ececa-54b6-4cfa-a272-a70100fb3610 -->","summary":"","htmlStringContent":"<!-- begin item 91aab846-185e-4e96-8d14-a70100fb333b --><!-- begin field 5192cc6f-3424-4672-858f-a70100fb3610 --><p><strong>Adverse effects of doxycycline include:</strong></p><ul><li>Gastrointestinal adverse effects, such as nausea, vomiting, and diarrhoea.</li><li>Photosensitivity (less common) — advise the person or their parents/carers to minimize their exposure to direct sunlight.</li><li>Benign intracranial hypertension has rarely been reported following treatment with a tetracycline.<ul><li>If a person taking doxycyline develops headache and visual disturbances, the drug should be stopped immediately.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/cough-acute-with-chest-signs-in-children/references/\">ABPI, 2016a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/cough-acute-with-chest-signs-in-children/references/\">BNF 72, 2016</a>]</p><!-- end field 5192cc6f-3424-4672-858f-a70100fb3610 --><!-- end item 91aab846-185e-4e96-8d14-a70100fb333b -->","subChapters":[]},{"id":"ea2bd86a-ed80-5e3f-bce9-9463b64f14c2","slug":"drug-interactions","fullItemName":"Drug interactions","depth":3,"htmlHeader":"<!-- begin field 2e7bdd5b-90e4-4540-81a1-a70100fb5729 --><h3>Drug interactions</h3><!-- end field 2e7bdd5b-90e4-4540-81a1-a70100fb5729 -->","summary":"","htmlStringContent":"<!-- begin item 6e60bf6f-fe75-43f0-a2cf-a70100fb5305 --><!-- begin field 1cd2d542-1f1b-4ad9-b51c-a70100fb5729 --><p><strong>Possible drug interactions with doxycycline include:</strong></p><ul><li><strong>Phenobarbital, carbamazepine, phenytoin, and primidone</strong> — metabolism of doxycycline may be accelerated by these drugs, leading to a reduced plasma concentration.<ul><li>Monitor the therapeutic effect of doxycyline, as a dose increase may be necessary.</li></ul></li><li><strong>Rifampicin</strong> — may cause a reduction in doxycycline levels, leading to undertreatment.<ul><li>Monitor the effects of concurrent use and increase the doxycycline dosage as necessary.</li></ul></li><li><strong>Sucralfate and antacids</strong> — can reduce the absorption of tetracyclines.<ul><li>Advise the person taking a tetracycline to wait at least 2 hours before taking sucralfate or antacids.</li></ul></li></ul><p> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/cough-acute-with-chest-signs-in-children/references/\">Preston, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/cough-acute-with-chest-signs-in-children/references/\">ABPI, 2016a</a>] </p><!-- end field 1cd2d542-1f1b-4ad9-b51c-a70100fb5729 --><!-- end item 6e60bf6f-fe75-43f0-a2cf-a70100fb5305 -->","subChapters":[]},{"id":"6f14860b-a156-5e1e-9ee8-bb86c93a4e68","slug":"dosing-information","fullItemName":"Dosing information","depth":3,"htmlHeader":"<!-- begin field 570cd0b4-17ac-4e9e-a61b-a70100fb717a --><h3>Dosing information</h3><!-- end field 570cd0b4-17ac-4e9e-a61b-a70100fb717a -->","summary":"","htmlStringContent":"<!-- begin item ef72335b-1a66-46d8-b7ac-a70100fb6e9a --><!-- begin field 603d2ece-1824-4277-bc61-a70100fb717a --><ul><li>Age 12 to 16 years – 200 mg on first day, then 100 mg daily; severe infections, 200 mg daily.</li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/cough-acute-with-chest-signs-in-children/references/\">BNF 72, 2016</a>]</p><!-- end field 603d2ece-1824-4277-bc61-a70100fb717a --><!-- end item ef72335b-1a66-46d8-b7ac-a70100fb6e9a -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}